

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.45233253 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95539401 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95539401 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.92657427 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.92657427 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69629880 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57285273 |
| 8 | viral transcription (GO:0019083) | 5.31952301 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21891086 |
| 10 | translational termination (GO:0006415) | 5.08766265 |
| 11 | DNA deamination (GO:0045006) | 5.00476480 |
| 12 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.85225559 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.85138088 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.51286049 |
| 15 | translational elongation (GO:0006414) | 4.49188884 |
| 16 | ribosomal small subunit biogenesis (GO:0042274) | 4.45648211 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.40720792 |
| 18 | cytidine metabolic process (GO:0046087) | 4.40045791 |
| 19 | cytidine catabolic process (GO:0006216) | 4.40045791 |
| 20 | cytidine deamination (GO:0009972) | 4.40045791 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 4.30077146 |
| 22 | protein targeting to ER (GO:0045047) | 4.27853881 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.17702712 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.09560225 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 4.09441964 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.07397556 |
| 27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.02544347 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.02049890 |
| 29 | maturation of SSU-rRNA (GO:0030490) | 3.98106767 |
| 30 | viral life cycle (GO:0019058) | 3.93919885 |
| 31 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.93667094 |
| 32 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.93667094 |
| 33 | cellular protein complex disassembly (GO:0043624) | 3.83537174 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.82245405 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.69291338 |
| 36 | regulation of B cell differentiation (GO:0045577) | 3.67101017 |
| 37 | negative T cell selection (GO:0043383) | 3.65488982 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.65224227 |
| 39 | response to interleukin-15 (GO:0070672) | 3.65048670 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.64667236 |
| 41 | B cell mediated immunity (GO:0019724) | 3.63277928 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.63248322 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.62247043 |
| 44 | translational initiation (GO:0006413) | 3.61386035 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.60525368 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.60138775 |
| 47 | detection of bacterium (GO:0016045) | 3.59676617 |
| 48 | T cell homeostasis (GO:0043029) | 3.55255371 |
| 49 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.54697074 |
| 50 | mast cell activation (GO:0045576) | 3.52686963 |
| 51 | response to interferon-beta (GO:0035456) | 3.51745962 |
| 52 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.49955127 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.49931261 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49094376 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.47413474 |
| 56 | protein complex disassembly (GO:0043241) | 3.46815725 |
| 57 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.45014388 |
| 58 | positive thymic T cell selection (GO:0045059) | 3.44218772 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.42176506 |
| 60 | leukocyte aggregation (GO:0070486) | 3.41248323 |
| 61 | platelet dense granule organization (GO:0060155) | 3.39338380 |
| 62 | tolerance induction (GO:0002507) | 3.38190684 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.36894518 |
| 64 | detection of other organism (GO:0098543) | 3.36019851 |
| 65 | definitive hemopoiesis (GO:0060216) | 3.35061216 |
| 66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.32284272 |
| 67 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.31580007 |
| 68 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.31280730 |
| 69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28694127 |
| 70 | positive regulation of cell killing (GO:0031343) | 3.27001725 |
| 71 | defense response to protozoan (GO:0042832) | 3.26736464 |
| 72 | mature B cell differentiation involved in immune response (GO:0002313) | 3.26469487 |
| 73 | lymph node development (GO:0048535) | 3.24432130 |
| 74 | macromolecular complex disassembly (GO:0032984) | 3.23655006 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22157072 |
| 76 | regulation of cell killing (GO:0031341) | 3.21638450 |
| 77 | activated T cell proliferation (GO:0050798) | 3.20610641 |
| 78 | regulation of tolerance induction (GO:0002643) | 3.20325738 |
| 79 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.19595582 |
| 80 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18300860 |
| 81 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17435957 |
| 82 | interferon-gamma production (GO:0032609) | 3.17219129 |
| 83 | Peyers patch development (GO:0048541) | 3.16546050 |
| 84 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.16546050 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15997853 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15890952 |
| 87 | lymphocyte migration (GO:0072676) | 3.13937625 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13647773 |
| 89 | positive regulation of granulocyte differentiation (GO:0030854) | 3.13620759 |
| 90 | T cell migration (GO:0072678) | 3.13051016 |
| 91 | response to protozoan (GO:0001562) | 3.12937148 |
| 92 | actin nucleation (GO:0045010) | 3.12877565 |
| 93 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.12596429 |
| 94 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.11630092 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 3.08138878 |
| 96 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.07551893 |
| 97 | response to type I interferon (GO:0034340) | 3.07410610 |
| 98 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.07226708 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.07226708 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 3.07226708 |
| 101 | positive regulation by symbiont of host defense response (GO:0052509) | 3.07226708 |
| 102 | modulation by symbiont of host defense response (GO:0052031) | 3.07226708 |
| 103 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.07226708 |
| 104 | type I interferon signaling pathway (GO:0060337) | 3.06319259 |
| 105 | cellular response to type I interferon (GO:0071357) | 3.06319259 |
| 106 | respiratory burst (GO:0045730) | 3.05063042 |
| 107 | megakaryocyte development (GO:0035855) | 3.04239449 |
| 108 | negative regulation of T cell apoptotic process (GO:0070233) | 3.03422334 |
| 109 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.02171467 |
| 110 | negative regulation of innate immune response (GO:0045824) | 3.02170166 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00955794 |
| 112 | T cell receptor signaling pathway (GO:0050852) | 3.00345180 |
| 113 | mRNA catabolic process (GO:0006402) | 2.99102249 |
| 114 | mast cell activation involved in immune response (GO:0002279) | 2.98742204 |
| 115 | mast cell degranulation (GO:0043303) | 2.98742204 |
| 116 | lymphoid progenitor cell differentiation (GO:0002320) | 2.98382858 |
| 117 | DNA strand elongation (GO:0022616) | 2.97762631 |
| 118 | positive regulation of tolerance induction (GO:0002645) | 2.97750189 |
| 119 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96796584 |
| 120 | mature B cell differentiation (GO:0002335) | 2.96197153 |
| 121 | thymic T cell selection (GO:0045061) | 2.95793970 |
| 122 | regulation of alpha-beta T cell activation (GO:0046634) | 2.92903628 |
| 123 | negative regulation of phagocytosis (GO:0050765) | 2.91626736 |
| 124 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.90533724 |
| 125 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.90499395 |
| 126 | neutrophil activation involved in immune response (GO:0002283) | 2.90226923 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88899679 |
| 128 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.85885008 |
| 129 | negative regulation of viral genome replication (GO:0045071) | 2.85165669 |
| 130 | lymphocyte homeostasis (GO:0002260) | 2.84766427 |
| 131 | ribosomal large subunit biogenesis (GO:0042273) | 2.84474890 |
| 132 | RNA catabolic process (GO:0006401) | 2.82722015 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81667345 |
| 134 | telomere maintenance via recombination (GO:0000722) | 2.81655495 |
| 135 | cellular response to interferon-beta (GO:0035458) | 2.80956532 |
| 136 | protein targeting to membrane (GO:0006612) | 2.80943979 |
| 137 | leukocyte homeostasis (GO:0001776) | 2.80869783 |
| 138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78896501 |
| 139 | T cell selection (GO:0045058) | 2.75750917 |
| 140 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74683475 |
| 141 | positive T cell selection (GO:0043368) | 2.73546822 |
| 142 | lymphocyte costimulation (GO:0031294) | 2.73353543 |
| 143 | myeloid dendritic cell activation (GO:0001773) | 2.73201718 |
| 144 | T cell costimulation (GO:0031295) | 2.70989351 |
| 145 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70539079 |
| 146 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66468123 |
| 147 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.64806507 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.64591549 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 2.64391981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.82602765 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.82898751 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41863066 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26432091 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.08678997 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.06936511 |
| 7 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.98349493 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94642547 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94341207 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93340946 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89343354 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86676859 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.78836960 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.66235361 |
| 15 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58321316 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56670343 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43758481 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42279071 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32228674 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.31753262 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30466263 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29970113 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.18740510 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10983949 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.04995193 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.02256981 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01527639 |
| 28 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01125235 |
| 29 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.99461406 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.97108204 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93029256 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.92831586 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 1.92372862 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90958688 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89958115 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89532090 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88949721 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88703101 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86066857 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82445995 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80970762 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80968960 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79944637 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79021310 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76580129 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75298177 |
| 47 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73673504 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72649771 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67459912 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64223224 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.64169023 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63647413 |
| 53 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.62973751 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.62526677 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60906278 |
| 56 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59722871 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59556377 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58132324 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52940726 |
| 60 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51791171 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.49060204 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48275483 |
| 63 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47247955 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46624493 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45109059 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44652864 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43966087 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40073209 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39148584 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36111154 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35766623 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32802185 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32348634 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31250974 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30490530 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29393157 |
| 77 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28895794 |
| 78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27919422 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26509898 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25535588 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24326136 |
| 82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23284427 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22971437 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20821458 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20542429 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20225240 |
| 87 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.20007385 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19859500 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19537479 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19529701 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19193070 |
| 92 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18009859 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16585418 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16581305 |
| 95 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15305724 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12726463 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12613435 |
| 98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12124851 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 1.11294339 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10878561 |
| 101 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09892800 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06684912 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06574497 |
| 104 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06221134 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06029164 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05337795 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04610921 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04014149 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02817829 |
| 110 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02584246 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 1.02265600 |
| 112 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01842222 |
| 113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01732405 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01203581 |
| 115 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99766201 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98437216 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.97093637 |
| 118 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96933425 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95273025 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94855983 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93026938 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92613552 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92285948 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90623743 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89565636 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89496029 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89327976 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88798439 |
| 129 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88673437 |
| 130 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88516076 |
| 131 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87168939 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85524920 |
| 133 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85454929 |
| 134 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84966557 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83694969 |
| 136 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82895267 |
| 137 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81690229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.14755745 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06964972 |
| 3 | MP0005671_abnormal_response_to | 3.90115450 |
| 4 | MP0000685_abnormal_immune_system | 3.77984884 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.75344156 |
| 6 | MP0001800_abnormal_humoral_immune | 3.13387870 |
| 7 | MP0009785_altered_susceptibility_to | 3.08490219 |
| 8 | * MP0002398_abnormal_bone_marrow | 2.86660128 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.72643608 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.69397305 |
| 11 | MP0002723_abnormal_immune_serum | 2.66363561 |
| 12 | MP0005387_immune_system_phenotype | 2.64436772 |
| 13 | MP0001790_abnormal_immune_system | 2.64436772 |
| 14 | * MP0001819_abnormal_immune_cell | 2.64383121 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.60674673 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.56550627 |
| 17 | MP0005025_abnormal_response_to | 2.55225179 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.43616490 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.43373855 |
| 20 | * MP0000716_abnormal_immune_system | 2.42753705 |
| 21 | * MP0002722_abnormal_immune_system | 2.34254756 |
| 22 | MP0001873_stomach_inflammation | 2.26957917 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.22801912 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.20989852 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.20592710 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.16132698 |
| 27 | * MP0002429_abnormal_blood_cell | 2.13497738 |
| 28 | MP0002006_tumorigenesis | 2.13159343 |
| 29 | MP0003866_abnormal_defecation | 2.09865563 |
| 30 | MP0003436_decreased_susceptibility_to | 2.07569888 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.07236327 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 2.02914353 |
| 33 | MP0001545_abnormal_hematopoietic_system | 2.02914353 |
| 34 | MP0003724_increased_susceptibility_to | 2.00605484 |
| 35 | MP0002405_respiratory_system_inflammati | 1.97109909 |
| 36 | MP0005174_abnormal_tail_pigmentation | 1.92864668 |
| 37 | MP0000490_abnormal_crypts_of | 1.91674505 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.91350586 |
| 39 | MP0002419_abnormal_innate_immunity | 1.82155494 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.76493118 |
| 41 | MP0001853_heart_inflammation | 1.75320316 |
| 42 | MP0003693_abnormal_embryo_hatching | 1.70060798 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.60513978 |
| 44 | MP0002095_abnormal_skin_pigmentation | 1.58267090 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.54237393 |
| 46 | MP0002933_joint_inflammation | 1.50692134 |
| 47 | MP0008057_abnormal_DNA_replication | 1.49610672 |
| 48 | MP0006082_CNS_inflammation | 1.48038134 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.46818609 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.43846425 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.38740003 |
| 52 | MP0003077_abnormal_cell_cycle | 1.38527815 |
| 53 | MP0004947_skin_inflammation | 1.38435764 |
| 54 | MP0008058_abnormal_DNA_repair | 1.37662216 |
| 55 | MP0004957_abnormal_blastocyst_morpholog | 1.36255668 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.35488368 |
| 57 | MP0009379_abnormal_foot_pigmentation | 1.32981097 |
| 58 | MP0002132_abnormal_respiratory_system | 1.19291766 |
| 59 | MP0008469_abnormal_protein_level | 1.17229230 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.10344117 |
| 61 | MP0000858_altered_metastatic_potential | 1.05245038 |
| 62 | MP0006054_spinal_hemorrhage | 1.05154001 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.02629713 |
| 64 | MP0005310_abnormal_salivary_gland | 1.01732051 |
| 65 | MP0009278_abnormal_bone_marrow | 1.00512041 |
| 66 | MP0003111_abnormal_nucleus_morphology | 0.98735283 |
| 67 | MP0003045_fibrosis | 0.98203857 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.94809700 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.92885284 |
| 70 | MP0000313_abnormal_cell_death | 0.90934359 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.89996026 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 0.89642496 |
| 73 | MP0004510_myositis | 0.87929772 |
| 74 | MP0004147_increased_porphyrin_level | 0.87917198 |
| 75 | MP0005166_decreased_susceptibility_to | 0.84677158 |
| 76 | MP0003943_abnormal_hepatobiliary_system | 0.84046055 |
| 77 | MP0004381_abnormal_hair_follicle | 0.80398739 |
| 78 | MP0003303_peritoneal_inflammation | 0.78744459 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.78516833 |
| 80 | MP0001533_abnormal_skeleton_physiology | 0.77769665 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.75231885 |
| 82 | MP0003786_premature_aging | 0.75161721 |
| 83 | MP0005451_abnormal_body_composition | 0.74801566 |
| 84 | MP0001663_abnormal_digestive_system | 0.69926360 |
| 85 | MP0009763_increased_sensitivity_to | 0.68141991 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.65946759 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.65221474 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.63860969 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.63332084 |
| 90 | MP0003075_altered_response_to | 0.63058300 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.62238599 |
| 92 | MP0005390_skeleton_phenotype | 0.62223487 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.61763812 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.60125269 |
| 95 | MP0009764_decreased_sensitivity_to | 0.55877440 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.55337019 |
| 97 | MP0000604_amyloidosis | 0.54731797 |
| 98 | MP0003448_altered_tumor_morphology | 0.53455345 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.53272890 |
| 100 | MP0003252_abnormal_bile_duct | 0.51962054 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.51775297 |
| 102 | MP0006292_abnormal_olfactory_placode | 0.51590446 |
| 103 | MP0000350_abnormal_cell_proliferation | 0.50394500 |
| 104 | MP0000249_abnormal_blood_vessel | 0.49824624 |
| 105 | MP0002075_abnormal_coat/hair_pigmentati | 0.48914797 |
| 106 | MP0003795_abnormal_bone_structure | 0.48394168 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.47653722 |
| 108 | MP0001851_eye_inflammation | 0.47324894 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.46942779 |
| 110 | MP0002009_preneoplasia | 0.46897209 |
| 111 | MP0000598_abnormal_liver_morphology | 0.46720925 |
| 112 | MP0009840_abnormal_foam_cell | 0.45881082 |
| 113 | MP0000371_diluted_coat_color | 0.44562710 |
| 114 | MP0008873_increased_physiological_sensi | 0.44164969 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.44132964 |
| 116 | MP0008872_abnormal_physiological_respon | 0.43471827 |
| 117 | MP0004883_abnormal_blood_vessel | 0.43449830 |
| 118 | MP0005023_abnormal_wound_healing | 0.43177136 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.43061525 |
| 120 | MP0002083_premature_death | 0.42429364 |
| 121 | MP0001764_abnormal_homeostasis | 0.41079747 |
| 122 | MP0003186_abnormal_redox_activity | 0.40271417 |
| 123 | MP0008874_decreased_physiological_sensi | 0.39956850 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.39695134 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.39306216 |
| 126 | MP0002163_abnormal_gland_morphology | 0.38548716 |
| 127 | MP0008260_abnormal_autophagy | 0.37085585 |
| 128 | MP0000609_abnormal_liver_physiology | 0.37059871 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.35256227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.54958533 |
| 2 | Recurrent bronchitis (HP:0002837) | 5.19727251 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.96405172 |
| 4 | Chronic otitis media (HP:0000389) | 4.77237321 |
| 5 | Thrombocytosis (HP:0001894) | 4.74009656 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.38410217 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.36018396 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.29028157 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.20349409 |
| 10 | Aplastic anemia (HP:0001915) | 4.02673292 |
| 11 | IgG deficiency (HP:0004315) | 3.99664443 |
| 12 | Abnormality of B cell number (HP:0010975) | 3.98216560 |
| 13 | B lymphocytopenia (HP:0010976) | 3.98216560 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.98192167 |
| 15 | Abnormality of T cells (HP:0002843) | 3.96827589 |
| 16 | Myositis (HP:0100614) | 3.85701248 |
| 17 | T lymphocytopenia (HP:0005403) | 3.81812722 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81208497 |
| 19 | Obstructive lung disease (HP:0006536) | 3.81208497 |
| 20 | Increased IgM level (HP:0003496) | 3.78604381 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.75857887 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.75434024 |
| 23 | Recurrent viral infections (HP:0004429) | 3.64550168 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.62211144 |
| 25 | Reticulocytopenia (HP:0001896) | 3.61382868 |
| 26 | Nasal polyposis (HP:0100582) | 3.60808899 |
| 27 | Lymphopenia (HP:0001888) | 3.52983445 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52081355 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.43108280 |
| 30 | Optic neuritis (HP:0100653) | 3.43108280 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 3.40589146 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38844860 |
| 33 | Combined immunodeficiency (HP:0005387) | 3.37802367 |
| 34 | Thyroiditis (HP:0100646) | 3.37240345 |
| 35 | Meningitis (HP:0001287) | 3.31164512 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.29767554 |
| 37 | Petechiae (HP:0000967) | 3.27209125 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.16175436 |
| 39 | Cellulitis (HP:0100658) | 3.12988153 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.11553638 |
| 41 | Abnormality of the prostate (HP:0008775) | 3.09081597 |
| 42 | Pulmonary infiltrates (HP:0002113) | 3.05600942 |
| 43 | Bronchitis (HP:0012387) | 3.05119920 |
| 44 | Gastrointestinal stroma tumor (HP:0100723) | 3.04382388 |
| 45 | Recurrent sinusitis (HP:0011108) | 3.02714989 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01016996 |
| 47 | Chest pain (HP:0100749) | 2.96352710 |
| 48 | Hypoplasia of the thymus (HP:0000778) | 2.96231143 |
| 49 | Lymphoma (HP:0002665) | 2.94342846 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.93415050 |
| 51 | Chronic sinusitis (HP:0011109) | 2.91825607 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89550814 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89550814 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.86189479 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.84894857 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.82569869 |
| 57 | Urticaria (HP:0001025) | 2.79559480 |
| 58 | Poikiloderma (HP:0001029) | 2.77157354 |
| 59 | Pallor (HP:0000980) | 2.73212183 |
| 60 | Type 2 muscle fiber atrophy (HP:0003554) | 2.72644323 |
| 61 | Epistaxis (HP:0000421) | 2.60506589 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.58484035 |
| 63 | Vasculitis (HP:0002633) | 2.55617924 |
| 64 | Sepsis (HP:0100806) | 2.55409961 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.55087526 |
| 66 | Chronic diarrhea (HP:0002028) | 2.53356878 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.51722800 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.48157781 |
| 69 | Hypoproteinemia (HP:0003075) | 2.47952076 |
| 70 | Macrocytic anemia (HP:0001972) | 2.47621762 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.46414220 |
| 72 | Hemoptysis (HP:0002105) | 2.45280789 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.41078310 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.39552139 |
| 75 | Recurrent skin infections (HP:0001581) | 2.39386407 |
| 76 | Granulocytopenia (HP:0001913) | 2.39044942 |
| 77 | IgA deficiency (HP:0002720) | 2.38922200 |
| 78 | Papilloma (HP:0012740) | 2.38668656 |
| 79 | Verrucae (HP:0200043) | 2.38668656 |
| 80 | Encephalitis (HP:0002383) | 2.38069340 |
| 81 | Amaurosis fugax (HP:0100576) | 2.35732784 |
| 82 | Basal cell carcinoma (HP:0002671) | 2.32077091 |
| 83 | Pustule (HP:0200039) | 2.31055466 |
| 84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.30433185 |
| 85 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.30433185 |
| 86 | Microcytic anemia (HP:0001935) | 2.29682028 |
| 87 | Colitis (HP:0002583) | 2.27845992 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.26452539 |
| 89 | Type I transferrin isoform profile (HP:0003642) | 2.25975536 |
| 90 | Abnormal platelet function (HP:0011869) | 2.25930412 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.25930412 |
| 92 | Joint swelling (HP:0001386) | 2.25234730 |
| 93 | Pulmonary embolism (HP:0002204) | 2.25047724 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.24499359 |
| 95 | Leukocytosis (HP:0001974) | 2.23655708 |
| 96 | Hypochromic anemia (HP:0001931) | 2.23370313 |
| 97 | Prostate neoplasm (HP:0100787) | 2.22706447 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.22692157 |
| 99 | Acute hepatic failure (HP:0006554) | 2.21870880 |
| 100 | Neutropenia (HP:0001875) | 2.20084355 |
| 101 | Recurrent pneumonia (HP:0006532) | 2.19884306 |
| 102 | Increased IgE level (HP:0003212) | 2.19355738 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.17892127 |
| 104 | Osteomyelitis (HP:0002754) | 2.17266987 |
| 105 | Pancytopenia (HP:0001876) | 2.15612842 |
| 106 | Restrictive lung disease (HP:0002091) | 2.14913380 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14789503 |
| 108 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.13265983 |
| 109 | Skin rash (HP:0000988) | 2.11766107 |
| 110 | Gingivitis (HP:0000230) | 2.11601478 |
| 111 | Mediastinal lymphadenopathy (HP:0100721) | 2.10798470 |
| 112 | Stomatitis (HP:0010280) | 2.09745270 |
| 113 | Entropion (HP:0000621) | 2.09383245 |
| 114 | Gangrene (HP:0100758) | 2.05797784 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 2.05045095 |
| 116 | Myelodysplasia (HP:0002863) | 2.04503335 |
| 117 | Arterial thrombosis (HP:0004420) | 2.03862032 |
| 118 | Fatigue (HP:0012378) | 2.03370543 |
| 119 | Eosinophilia (HP:0001880) | 2.02283448 |
| 120 | Emphysema (HP:0002097) | 2.02006767 |
| 121 | Colon cancer (HP:0003003) | 2.01513340 |
| 122 | Skin ulcer (HP:0200042) | 2.01082467 |
| 123 | Acute lymphatic leukemia (HP:0006721) | 2.00590200 |
| 124 | Autoimmune thrombocytopenia (HP:0001973) | 2.00119097 |
| 125 | Recurrent otitis media (HP:0000403) | 1.99689034 |
| 126 | Abnormal protein glycosylation (HP:0012346) | 1.99412559 |
| 127 | Abnormal glycosylation (HP:0012345) | 1.99412559 |
| 128 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99412559 |
| 129 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99412559 |
| 130 | Orchitis (HP:0100796) | 1.97337426 |
| 131 | Gingival bleeding (HP:0000225) | 1.95561343 |
| 132 | Arthralgia (HP:0002829) | 1.92792207 |
| 133 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91998176 |
| 134 | Pulmonary fibrosis (HP:0002206) | 1.91997686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.06476594 |
| 2 | TXK | 3.08398078 |
| 3 | RIPK4 | 2.95559150 |
| 4 | NME2 | 2.91869587 |
| 5 | KIT | 2.79133659 |
| 6 | ZAP70 | 2.72553261 |
| 7 | EEF2K | 2.51124026 |
| 8 | BTK | 2.36177866 |
| 9 | KDR | 2.31544151 |
| 10 | JAK3 | 2.26105731 |
| 11 | TEC | 2.17185614 |
| 12 | FLT3 | 2.14356844 |
| 13 | STK16 | 2.02037212 |
| 14 | IKBKE | 1.99122196 |
| 15 | CSF1R | 1.94073218 |
| 16 | SYK | 1.88975723 |
| 17 | TBK1 | 1.77983029 |
| 18 | BLK | 1.73290954 |
| 19 | TGFBR1 | 1.71274992 |
| 20 | NLK | 1.64704342 |
| 21 | GRK6 | 1.64526771 |
| 22 | TYK2 | 1.63618013 |
| 23 | MAP3K12 | 1.63067294 |
| 24 | MAP3K10 | 1.59571308 |
| 25 | ACVR1B | 1.58963149 |
| 26 | TNIK | 1.57246628 |
| 27 | PRPF4B | 1.53352513 |
| 28 | TESK2 | 1.50831181 |
| 29 | CDK19 | 1.48178733 |
| 30 | LCK | 1.45709852 |
| 31 | WEE1 | 1.43700801 |
| 32 | ITK | 1.35978385 |
| 33 | STK10 | 1.29151992 |
| 34 | LRRK2 | 1.27515040 |
| 35 | MUSK | 1.25811593 |
| 36 | RPS6KB2 | 1.24196394 |
| 37 | PIM2 | 1.21580966 |
| 38 | IRAK4 | 1.20293111 |
| 39 | SCYL2 | 1.19570905 |
| 40 | LYN | 1.18179002 |
| 41 | MAP2K3 | 1.12285123 |
| 42 | TGFBR2 | 1.12135346 |
| 43 | IKBKB | 1.08522402 |
| 44 | ERN1 | 1.08100251 |
| 45 | TNK2 | 1.05113401 |
| 46 | FES | 1.04864572 |
| 47 | FGFR4 | 1.00836901 |
| 48 | RPS6KA4 | 1.00000083 |
| 49 | PIM1 | 0.97883466 |
| 50 | VRK2 | 0.96102320 |
| 51 | HCK | 0.93716490 |
| 52 | CLK1 | 0.93256677 |
| 53 | VRK1 | 0.91235239 |
| 54 | PASK | 0.89637405 |
| 55 | NEK2 | 0.89575880 |
| 56 | DYRK3 | 0.88766744 |
| 57 | EIF2AK1 | 0.88704698 |
| 58 | BUB1 | 0.88228734 |
| 59 | EIF2AK3 | 0.86676586 |
| 60 | CDC7 | 0.85093214 |
| 61 | MAPKAPK3 | 0.84953945 |
| 62 | PKN2 | 0.82852908 |
| 63 | ADRBK2 | 0.82073808 |
| 64 | JAK2 | 0.81420540 |
| 65 | JAK1 | 0.81026366 |
| 66 | MARK3 | 0.80166085 |
| 67 | MAP2K2 | 0.79802674 |
| 68 | MAP3K14 | 0.78420407 |
| 69 | CDK4 | 0.77592733 |
| 70 | BMPR2 | 0.77057696 |
| 71 | TLK1 | 0.76853979 |
| 72 | SMG1 | 0.76768635 |
| 73 | PDK1 | 0.68869274 |
| 74 | MAP3K1 | 0.68087492 |
| 75 | FYN | 0.67718229 |
| 76 | PRKD2 | 0.65925947 |
| 77 | CCNB1 | 0.65361503 |
| 78 | MATK | 0.65110268 |
| 79 | MAP3K13 | 0.64753668 |
| 80 | MAP2K6 | 0.64510921 |
| 81 | MAP3K7 | 0.63755826 |
| 82 | BRSK2 | 0.63588415 |
| 83 | SIK3 | 0.62186486 |
| 84 | TAOK2 | 0.61791374 |
| 85 | CDK8 | 0.61719578 |
| 86 | ZAK | 0.58441058 |
| 87 | ATR | 0.58067861 |
| 88 | MAPK11 | 0.57657521 |
| 89 | HIPK2 | 0.57027770 |
| 90 | CSK | 0.56582749 |
| 91 | TESK1 | 0.56222376 |
| 92 | EPHB1 | 0.55779550 |
| 93 | PIK3CG | 0.55681687 |
| 94 | CAMKK1 | 0.55402402 |
| 95 | MAPK4 | 0.55053009 |
| 96 | DAPK1 | 0.54929255 |
| 97 | GRK7 | 0.54294856 |
| 98 | SIK2 | 0.53990119 |
| 99 | FGFR3 | 0.53838152 |
| 100 | MYLK | 0.53797800 |
| 101 | SRPK1 | 0.53697523 |
| 102 | PRKCH | 0.52631015 |
| 103 | TAOK1 | 0.52601945 |
| 104 | MAPKAPK5 | 0.51476944 |
| 105 | CDK7 | 0.51109908 |
| 106 | FGR | 0.51052448 |
| 107 | PRKG2 | 0.50900156 |
| 108 | ILK | 0.50605480 |
| 109 | TAOK3 | 0.50251919 |
| 110 | MKNK1 | 0.49783618 |
| 111 | RAF1 | 0.48031841 |
| 112 | MAPK12 | 0.46695606 |
| 113 | MST4 | 0.45925723 |
| 114 | MAP3K3 | 0.45177115 |
| 115 | TIE1 | 0.44846605 |
| 116 | CHUK | 0.42490194 |
| 117 | MAP3K11 | 0.41588924 |
| 118 | MAPKAPK2 | 0.41226095 |
| 119 | AURKB | 0.39785878 |
| 120 | CAMK1 | 0.39606898 |
| 121 | DYRK1B | 0.37092013 |
| 122 | STK4 | 0.36342469 |
| 123 | CAMKK2 | 0.34656962 |
| 124 | RPS6KA5 | 0.33675945 |
| 125 | NUAK1 | 0.33576802 |
| 126 | PRKCQ | 0.33095553 |
| 127 | BCKDK | 0.33075955 |
| 128 | INSR | 0.30677418 |
| 129 | RPS6KA6 | 0.30673739 |
| 130 | ABL1 | 0.30537966 |
| 131 | MAPK7 | 0.30508950 |
| 132 | MAPK3 | 0.30142023 |
| 133 | MAP3K5 | 0.30114970 |
| 134 | RPS6KC1 | 0.29674536 |
| 135 | RPS6KL1 | 0.29674536 |
| 136 | PRKCD | 0.27412232 |
| 137 | PDPK1 | 0.23292674 |
| 138 | IGF1R | 0.20309498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.86037850 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.34577114 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.76217567 |
| 4 | Ras signaling pathway_Homo sapiens_hsa04014 | 3.28732843 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.13879661 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.92794837 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.57871322 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25012167 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21332237 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.18108002 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14978633 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14189577 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.11006652 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08887306 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.02558407 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.98985209 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.97450364 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96754238 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89656382 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.88112025 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.86005571 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.84915067 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.83425519 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.78230842 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63135004 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62046112 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.61402232 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53357749 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.50503938 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44915834 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41776653 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41342059 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30458667 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.22692722 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.22145371 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17660736 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14524873 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12318399 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08417189 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07112928 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.02086419 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01357228 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.00226636 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00076910 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98977466 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96209873 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96039760 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 0.95263159 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95144338 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.93670264 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.92657596 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.90503317 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88190622 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88111520 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86706277 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86702977 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85156516 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.83763649 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.82631400 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80844577 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80347618 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.79708453 |
| 63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79212412 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.78592148 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78146948 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74221232 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72121854 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71296528 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71221073 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70812870 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69732301 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69378130 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68689376 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67990170 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67110785 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65692236 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64572621 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62746095 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62741752 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61669971 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.59711470 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.58354645 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58207437 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57780121 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56805502 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54614799 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54406097 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.53488277 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52746891 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.51301623 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48664529 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45007723 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44344113 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.44170531 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43823755 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.41599848 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41384377 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39251558 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38392529 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38070203 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36147062 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35570752 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34011175 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33049866 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32817548 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.32317857 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30779508 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29901626 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28931835 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27872158 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27688503 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27567499 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27059906 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25946961 |
| 115 | Alcoholism_Homo sapiens_hsa05034 | 0.25552424 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21010946 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18941295 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17628435 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16902054 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16491311 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14795496 |
| 122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14665455 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12718082 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.11142024 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.10308295 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08501668 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.07074578 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.04455828 |
| 129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.01570395 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.00710328 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0121943 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0022716 |

